臨床試験を検索:FMX-103 1.5%
合計9620件
-
AerasEuropean and Developing Countries Clinical Trials Partnership (EDCTP)完了
-
University of Illinois at ChicagoRush University Medical Center; American Society for Parenteral and Enteral Nutrition完了
-
Duke UniversityNational Institute on Drug Abuse (NIDA)積極的、募集していない
-
Société des Produits Nestlé (SPN)Nutrasource Pharmaceutical and Nutraceutical Services, Inc.; Bruyere Research Institute終了しました
-
MediBeacon完了
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, Wisconsin完了
-
Fondation Ophtalmologique Adolphe de Rothschild完了
-
Immorna Biotherapeutics, Inc.ICON plc積極的、募集していない
-
Merck Sharp & Dohme LLC完了子宮頸癌 | 外陰がん | 膣がん | 生殖器疣贅 | ヒトパピローマウイルス
-
Massachusetts General HospitalMuscular Dystrophy Association完了
-
National Institute on Alcohol Abuse and Alcoholism...Brown University完了
-
Augusta UniversityAmerican Gastroenterological Association Foundation完了
-
Eli Lilly and Company完了注意欠陥多動性障害 | 反抗挑戦性障害イタリア
-
University of ChicagoNational Heart, Lung, and Blood Institute (NHLBI)完了
-
Minnesota Eye Consultants, P.A.Bausch & Lomb Incorporated完了
-
Castle Creek Biosciences, LLC.終了しました
-
University of Massachusetts, WorcesterGenentech, Inc.; Millennium Pharmaceuticals, Inc.終了しました
-
Ann & Robert H Lurie Children's Hospital of Chicago完了
-
Biocon LimitedJuvenile Diabetes Research Foundation; Profil Institut für Stoffwechselforschung GmbH終了しました
-
EXcorLab GmbHMembrana GmbH; Nikkiso Co. Ltd; Nikkiso Medical GmbH終了しました
-
University of North Carolina, Chapel HillThe Broad Foundation; Crohn's and Colitis Foundation; OpenBiome終了しました